Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for business professionals · Wednesday, July 10, 2024 · 726,480,427 Articles · 3+ Million Readers

Veterinary CRO And CDMO Market Analysis With opportunity segments

Veterinary CRO And CDMO Global Market Report 2024 –  Market Size, Trends, And Global Forecast 2024-2033

Veterinary CRO And CDMO Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs”
— The Business Research Company

LONDON, GREATER LONDON , UK, July 4, 2024 /EINPresswire.com/ -- The veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market has witnessed robust growth in recent years, driven by increasing regulatory compliance needs, globalization of the animal health market, and heightened drug development for livestock. According to the latest report, the market size is projected to grow from $6.44 billion in 2023 to $7.03 billion in 2024, marking a compound annual growth rate (CAGR) of 9.1%.

Driving Factors for Market Growth
The historic growth of the veterinary CRO and CDMO market can be attributed to several key factors including regulatory compliance needs, the globalization of the animal health market, increased drug development for livestock, and rising outsourcing by pharmaceutical companies. Looking forward, the market is expected to continue its upward trajectory, reaching $9.87 billion by 2028 with a CAGR of 8.9%. This growth will be driven by the increasing adoption of precision medicine, a focus on preventive healthcare, epidemiological surveillance, emergency preparedness, and the increasing complexity of veterinary therapeutics.

Explore the global veterinary CRO and CDMO market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=12080&type=smp

Veterinary CRO And CDMO Market Major Players and Market Trends
Key players such as Labcorp Drug Development India Private Limited, Zoetis Inc., Eurofins Scientific SE, and Pharmaceutical Product Development Inc. are actively driving market growth through innovation in service offerings. Companies are leveraging advanced technologies and strategic partnerships to enhance service capabilities and expand their global footprint. For instance, Zoetis Inc. launched AI-based blood smear testing on its Vetscan Imagyst
platform in 2022, revolutionizing in-clinic diagnostics for veterinary healthcare teams.

Veterinary CRO And CDMO Market Segmentation
The veterinary CRO and CDMO market is segmented based on service type, animal type, and application:
Service Type:
• Discovery
• Development
• Manufacturing
• Packaging and Labeling
• Market Approval and Post-marketing
Animal Type:
• Companion Animals
• Livestock Animals
Application:
• Medicines
• Medical Devices
• Pharmaceuticals
• Biologics
• Other Applications

Geographical Insights: North America Leads, Asia-Pacific to Witness Fastest Growth
North America emerged as the largest region in the veterinary CRO and CDMO market in 2023, driven by substantial investments in animal healthcare and advanced research capabilities. However, Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by increasing urbanization, rising disposable incomes, and growing awareness of animal health.

Explore the report store to make a direct purchase of the report:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Veterinary CRO And CDMO Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Veterinary CRO And CDMO Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on veterinary CRO and CDMO market size, veterinary CRO and CDMO market drivers and trends, veterinary CRO and CDMO market major players, competitors' revenues, market positioning, and market growth across geographies. The veterinary CRO and CDMO market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Veterinary Infectious Disease Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release